TJ Duncan-Moir, the second generation owner of Nottingham's A1 Flue Systems, explains how focusing on export opportunities has helped the company continue growing despite economic and global uncertainties...
Ria Blagburn tells us what her first year as owner of marketing start-up GrowBeyond has been like and what lessons she has learned so far...
Dr Jennifer Bailey, a senior associate at Marks & Clerk’s Birmingham office, says an Intellectual Property strategy is crucial, especially in such a fast-growing, competitive and lucrative global sector as healthcare.
Great challenges lie ahead for the West Midlands in the fields of health and care. We report on an economic summit where key decision makers came together to debate these issues.
Mark Stocks, the Birmingham-based head of Grant Thornton’s public sector assurance practice in the Midlands, and national lead of its health audit practice, looks at the regional healthcare economy.
Tony Davis, commercial director of the West Midlands Academic Health Science Network, explains why he thinks this region’s healthcare and life sciences sectors must do more to highlight their achievements and their goals.
BQ2 invited three high-profile members of Birmingham’s professional services community, to give their personal opinions on the challenges ahead for the region’s healthcare sector.
Birmingham City University has established an Institute for Health and Quality of Life. Its director, Susannah Goh, explains more about this ambitious initiative to Ian Halstead.
Birmingham has a global reputation for stratified medicine; allowing patients to receive treatments as personalised as their conditions. Ian Halstead talked to two specialists at the University of Birmingham who are tackling the scourge of lung cancer.
The University Hospitals Birmingham NHS Foundation Trust was named as a centre of digital excellence, by Health Secretary
Jeremy Hunt. Ian Halstead discovers more.
The Institute of Translational Medicine (ITM) is a world-class research institution which will progress the latest scientific advances into innovative treatments. Ian Halstead met its director, Professor Subrata Ghosh.